Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Epicore Bionetworks Inc. V.EBN

"Epicore Bionetworks Inc develops, manufactures and markets biotechnology products based on natural microbes and enzymes for the aquaculture, agriculture and municipal industries."


TSXV:EBN - Post by User

Comment by ChaseYourDreamon Oct 07, 2016 2:12pm
79 Views
Post# 25323565

RE:Admit it, you ARE reading my posts!

RE:Admit it, you ARE reading my posts!
AFS imminent. Trading volumes have been light, volatility low on high end of current valuation. No buying bargains offered.

ChaseYourDream wrote:
It seems like every time I post to praise the fundamentals of Epicore (and I don't have a position right now), something good happens. This time (on no news) the SP has crept to two new 52-month highs, on very light total volume.

So whoever is reading this, you want my next read?

AFS out mid-October. More likely to rise than fall in anticipation, but volatility likely to increase as some players try to cheapen it to accumulate before the numbers. On light overall volumes, manipulation is easy.

Actual AFS results likely will show a seasonal decline of revenues from Q3 to Q4... and if some shareholders are gullible, they may sell into lower ST SP fluctuations. Best time to buy, (unless .60 offered before the AFS).

The fundamentals will still be excellent for the longer term growth and value of the company, but until there is more sizzle, the steak may remain unappreciated. Likely to offer buying opportunities until a future quarter (Q1 or Q2 2017) surprises, confirming the year to year positive trend continues. It may not be right away, but someday soon $1/share will seem like a bargain.


<< Previous
Bullboard Posts
Next >>